Diabetes Clinical Trial
Official title:
HEdia eXercise Algorithm - HEXA Study. A Randomised Controlled Crossover Pilot Study
NCT number | NCT05458167 |
Other study ID # | HEXA study |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | April 3, 2023 |
Est. completion date | April 3, 2024 |
Verified date | June 2024 |
Source | Hedia ApS |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A randomised controlled crossover pilot study to evaluate safety and efficacy of a digital insulin bolus calculator with a physical activity module
Status | Completed |
Enrollment | 20 |
Est. completion date | April 3, 2024 |
Est. primary completion date | April 3, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: - Signed informed consent. - Ability to understand, speak and read Danish fluently. - Diagnosis of type 1 diabetes mellitus for =12 months. - Age between =18 and <60 years. - Minimum one measurement of HbA1c between 6.0 to 8.6 % (42 to 70 mmol/mol) within the last four months. If several measurements, then it is the latest one that counts. - Body mass index (BMI) between =18.5 and <30 kg/m2. - Ability to use an Apple® (iOS version 13 and up) or Android® (Android version 8.0 and up) smartphone. - Treated with the same pen-based insulin regimen with basal insulin (insulin glargine, degludec, or detemir) and meal time insulin (insulin aspart, lispro, glulisine) for at least the three preceding months. - Patients who can perform 45 min. of exercise at moderate intensity on an ergometer bike (investigator assessment). - If female participants of childbearing potential; willing to have a pregnancy test performed and to use a highly effective method of contraception. Exclusion Criteria: - Already using Hedia Diabetes Assistant. - Use of human insulin or premixed insulin. - Blood pressure > 180/105 mmHg. - Treatment with sodium-glucose transporter 2-inhibitors, glucagon-like peptide 1 receptor agonists, or glucocorticoids. - Job situation entailing night shifts. - Fever. - A mental state impeding compliance with the protocol. - Expected non-compliance with the protocol at the discretion of the principal investigator. - Pregnancy. - Breast-feeding. - Dialysis therapy or eGFR < 60 ml/min. - Patients diagnosed with claudicatio intermittens, heart failure, ischaemic heart disease or stroke. - Patients prescribed with beta blockers. - Abuse of alcohol or drugs in the past two years. - On-going participation, or participation within the last 3 months, in an organised clinical study in which participants received study medication (investigator assessment). - Surgery scheduled for the study duration period. - An episode of diabetic ketoacidosis or severe hypoglycaemia requiring third-party assistance within the preceding 6 months. - Known gastroparesis. |
Country | Name | City | State |
---|---|---|---|
Denmark | North Zealand Hospital - Hillerød | Hillerød |
Lead Sponsor | Collaborator |
---|---|
Hedia ApS |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Glycemic variability of Hedia Diabetes Assistant bolus calculator with physical activity module | To compare the efficacy of the physical activity module as part of the Hedia Diabetes Assistant bolus calculator compared to the participants' habitual diabetes management during a 24-hour period starting one hour before exercise in adults with type 1 diabetes mellitus in terms of glycaemic variability (coefficient of variation and standard deviation). | 24-hour period starting one hour before exercise | |
Other | Daily insulin requirement of Hedia Diabetes Assistant bolus calculator with physical activity module | To compare the daily intake of insulin in adults with type 1 diabetes mellitus utilising the physical activity module as part of the Hedia Diabetes Assistant bolus calculator compared to their habitual diabetes management during a 24-hour period starting one hour before exercise. | 24-hour period starting one hour before exercise | |
Other | Daily correctional actions of Hedia Diabetes Assistant bolus calculator with physical activity module | To compare the number of daily correctional actions (intake of food or injection of insulin) in adults with type 1 diabetes mellitus utilising the physical activity module as part of the Hedia Diabetes Assistant bolus calculator compared to their habitual diabetes management during a 24-hour period starting one hour before exercise. | 24-hour period starting one hour before exercise | |
Other | Usability of Hedia Diabetes Assistant bolus calculator with physical activity module | To compare the usability of the physical activity module as part of the Hedia Diabetes Assistant application by System Usability Scale (SUS) in adult patients with type 1 diabetes mellitus. | 1 day | |
Primary | Time-in-range of Hedia Diabetes Assistant bolus calculator with physical activity module | To compare the efficacy of the physical activity module as part of the Hedia Diabetes Assistant bolus calculator compared to the participants' habitual diabetes management during a 24-hour period starting one hour before exercise in adults with type 1 diabetes mellitus in terms of time-in-range (blood glucose 3.9-10.0 mmol/l). | 24-hour period starting one hour before exercise | |
Secondary | Hypoglycemic events of Hedia Diabetes Assistant bolus calculator with physical activity module | To compare the efficacy of the physical activity module as part of the Hedia Diabetes Assistant bolus calculator compared to the participants' habitual diabetes management during a 24-hour period starting one hour before exercise in adults with type 1 diabetes mellitus in terms of no. of hypoglycemic events (blood glucose < 3.9 mmol/l). | 24-hour period starting one hour before exercise | |
Secondary | Time-above-range of Hedia Diabetes Assistant bolus calculator with physical activity module | To compare the efficacy of the physical activity module as part of the Hedia Diabetes Assistant bolus calculator compared to the participants' habitual diabetes management during a 24-hour period starting one hour before exercise in adults with type 1 diabetes mellitus in terms of time-above-range (>10.0 mmol/l). | 24-hour period starting one hour before exercise | |
Secondary | Time-below-range of Hedia Diabetes Assistant bolus calculator with physical activity module | To compare the efficacy of the physical activity module as part of the Hedia Diabetes Assistant bolus calculator compared to the participants' habitual diabetes management during a 24-hour period starting one hour before exercise in adults with type 1 diabetes mellitus in terms of time-below-range (blood glucose < 3.9 mmol/l). | 24-hour period starting one hour before exercise |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05594446 -
Morphometric Study of the Legs and Feet of Diabetic Patients in Order to Collect Data Intended to be Used to Measure by Dynamometry the Pressures Exerted by Several Medical Compression Socks at the Level of the Forefoot
|
||
Completed |
NCT03975309 -
DHS MIND Metabolomics
|
||
Completed |
NCT01855399 -
Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes
|
N/A | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Recruiting |
NCT04984226 -
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
|
Phase 2 | |
Recruiting |
NCT05007990 -
Caregiving Networks Across Disease Context and the Life Course
|
||
Active, not recruiting |
NCT04420936 -
Pragmatic Research in Healthcare Settings to Improve Diabetes and Obesity Prevention and Care for Our Program
|
N/A | |
Recruiting |
NCT03549559 -
Imaging Histone Deacetylase in the Heart
|
N/A | |
Completed |
NCT04903496 -
Clinical Characteristics and Disease Burden of Diabetic Patients Based on Tianjin Regional Database
|
||
Completed |
NCT01437592 -
Investigating the Pharmacokinetic Properties of NN1250 in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT03390179 -
Hyperglycemic Response and Steroid Administration After Surgery (DexGlySurgery)
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Recruiting |
NCT05294822 -
Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes
|
N/A | |
Completed |
NCT04427982 -
Dance and Diabetes/Prediabetes Self-Management
|
N/A | |
Completed |
NCT02356848 -
STEP UP to Avert Amputation in Diabetes
|
N/A | |
Completed |
NCT03292185 -
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
|
Phase 1 | |
Active, not recruiting |
NCT05477368 -
Examining the Feasibility of Prolonged Ketone Supplement Drink Consumption in Adults With Type 2 Diabetes
|
N/A | |
Completed |
NCT04496401 -
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
|
Phase 4 |